{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:04:40Z","timestamp":1789643080506,"version":"4.0.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"DOI":"10.1007\/s10585-026-10431-z","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T10:54:08Z","timestamp":1789642448000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bone marrow adipose tissue: fueling breast cancer bone metastasis via pro-tumor mechanisms and novel therapeutic targets"],"prefix":"10.1007","volume":"43","author":[{"given":"Mengyao","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bangxi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Run","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyang","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanwu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"10431_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21144967","author":"E Shin","year":"2020","unstructured":"Shin E, Koo JS (2020) The role of adipokines and bone marrow adipocytes in breast cancer bone metastasis. Int J Mol Sci 21(14):4967. https:\/\/doi.org\/10.3390\/ijms21144967","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10431_CR2","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.neo.2015.11.005","volume":"17","author":"ZS Templeton","year":"2015","unstructured":"Templeton ZS et al (2015) Breast cancer cell colonization of the human bone marrow adipose tissue niche. Neoplasia 17(12):849\u2013861. https:\/\/doi.org\/10.1016\/j.neo.2015.11.005","journal-title":"Neoplasia"},{"key":"10431_CR3","doi-asserted-by":"publisher","first-page":"902033","DOI":"10.3389\/fendo.2022.902033","volume":"13","author":"Y Li","year":"2022","unstructured":"Li Y et al (2022) Distinct metabolism of bone marrow adipocytes and their role in bone metastasis. Front Endocrinol (Lausanne) 13:902033. https:\/\/doi.org\/10.3389\/fendo.2022.902033","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10431_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21031051","author":"P Maroni","year":"2020","unstructured":"Maroni P (2020) Leptin, adiponectin, and Sam68 in bone metastasis from breast cancer. Int J Mol Sci 21(3):1051. https:\/\/doi.org\/10.3390\/ijms21031051","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10431_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41413-023-00260-1","volume":"11","author":"Y Huang","year":"2023","unstructured":"Huang Y et al (2023) Bone serves as a transfer station for secondary dissemination of breast cancer. Bone Res 11(1):21. https:\/\/doi.org\/10.1038\/s41413-023-00260-1","journal-title":"Bone Res"},{"issue":"2","key":"10431_CR6","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s10585-021-10076-0","volume":"38","author":"S Soni","year":"2021","unstructured":"Soni S, Torvund M, Mandal CC (2021) Molecular insights into the interplay between adiposity, breast cancer and bone metastasis. Clin Exp Metastasis 38(2):119\u2013138. https:\/\/doi.org\/10.1007\/s10585-021-10076-0","journal-title":"Clin Exp Metastasis"},{"key":"10431_CR7","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3389\/fendo.2018.00339","volume":"9","author":"G Luo","year":"2018","unstructured":"Luo G, He Y, Yu X (2018) Bone marrow adipocyte: an intimate partner with tumor cells in bone metastasis. Front Endocrinol (Lausanne) 9:339. https:\/\/doi.org\/10.3389\/fendo.2018.00339","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"10431_CR8","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/s41571-021-00499-9","volume":"18","author":"LC Hofbauer","year":"2021","unstructured":"Hofbauer LC et al (2021) Novel approaches to target the microenvironment of bone metastasis. Nat Rev Clin Oncol 18(8):488\u2013505. https:\/\/doi.org\/10.1038\/s41571-021-00499-9","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"10431_CR9","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s10555-022-10042-6","volume":"41","author":"M Hernandez","year":"2022","unstructured":"Hernandez M et al (2022) The role of bone marrow adipocytes in cancer progression: the impact of obesity. Cancer Metastasis Rev 41(3):589\u2013605. https:\/\/doi.org\/10.1007\/s10555-022-10042-6","journal-title":"Cancer Metastasis Rev"},{"key":"10431_CR10","doi-asserted-by":"publisher","first-page":"108274","DOI":"10.1016\/j.pharmthera.2022.108274","volume":"238","author":"A Wilson","year":"2022","unstructured":"Wilson A, Garmo LC, Podgorski I (2022) Interplay between fat cells and immune cells in bone: impact on malignant progression and therapeutic response. Pharmacol Ther 238:108274. https:\/\/doi.org\/10.1016\/j.pharmthera.2022.108274","journal-title":"Pharmacol Ther"},{"issue":"3","key":"10431_CR11","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.clbc.2017.01.004","volume":"17","author":"G Li","year":"2017","unstructured":"Li G et al (2017) Magnetic resonance spectroscopy-detected change in marrow adiposity is strongly correlated to postmenopausal breast cancer risk. Clin Breast Cancer 17(3):239\u2013244. https:\/\/doi.org\/10.1016\/j.clbc.2017.01.004","journal-title":"Clin Breast Cancer"},{"key":"10431_CR12","doi-asserted-by":"publisher","first-page":"561595","DOI":"10.3389\/fonc.2020.561595","volume":"10","author":"C Liu","year":"2020","unstructured":"Liu C, Zhao Q, Yu X (2020) Bone marrow adipocytes, adipocytokines, and breast cancer cells: novel implications in bone metastasis of breast cancer. Front Oncol 10:561595. https:\/\/doi.org\/10.3389\/fonc.2020.561595","journal-title":"Front Oncol"},{"key":"10431_CR13","doi-asserted-by":"publisher","first-page":"1207416","DOI":"10.3389\/fendo.2023.1207416","volume":"14","author":"F Salamanna","year":"2023","unstructured":"Salamanna F et al (2023) Role of bone marrow adipocytes in bone metastasis development and progression: a systematic review. Front Endocrinol (Lausanne) 14:1207416. https:\/\/doi.org\/10.3389\/fendo.2023.1207416","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"12","key":"10431_CR14","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1002\/jbmr.3618","volume":"33","author":"J Fornetti","year":"2018","unstructured":"Fornetti J, Welm AL, Stewart SA (2018) Understanding the bone in cancer metastasis. J Bone Min Res 33(12):2099\u20132113. https:\/\/doi.org\/10.1002\/jbmr.3618","journal-title":"J Bone Min Res"},{"key":"10431_CR15","doi-asserted-by":"publisher","first-page":"903925","DOI":"10.3389\/fendo.2022.903925","volume":"13","author":"MOC Otley","year":"2022","unstructured":"Otley MOC, Sinal CJ (2022) Adipocyte-cancer cell interactions in the bone microenvironment. Front Endocrinol (Lausanne) 13:903925. https:\/\/doi.org\/10.3389\/fendo.2022.903925","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10431_CR16","doi-asserted-by":"publisher","first-page":"123341","DOI":"10.1016\/j.biomaterials.2025.123341","volume":"322","author":"A Bessot","year":"2025","unstructured":"Bessot A et al (2025) Bone marrow adipocytes in cancer: mechanisms, models, and therapeutic implications. Biomaterials 322:123341. https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123341","journal-title":"Biomaterials"},{"issue":"3","key":"10431_CR17","doi-asserted-by":"publisher","first-page":"5521","DOI":"10.1002\/cphy.c230016","volume":"14","author":"X Zhang","year":"2024","unstructured":"Zhang X et al (2024) Function and regulation of bone marrow adipose tissue in health and disease: state of the field and clinical considerations. Compr Physiol 14(3):5521\u20135579. https:\/\/doi.org\/10.1002\/cphy.c230016","journal-title":"Compr Physiol"},{"key":"10431_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13030364","author":"MR Reagan","year":"2021","unstructured":"Reagan MR, Fairfield H, Rosen CJ (2021) Bone marrow adipocytes: a link between obesity and bone cancer. Cancers (Basel) 13(3):364. https:\/\/doi.org\/10.3390\/cancers13030364","journal-title":"Cancers (Basel)"},{"key":"10431_CR19","doi-asserted-by":"publisher","first-page":"117684","DOI":"10.1016\/j.bone.2025.117684","volume":"202","author":"P Luo","year":"2026","unstructured":"Luo P et al (2026) The association between body roundness index and lumbar marrow fat content in postmenopausal women. Bone 202:117684. https:\/\/doi.org\/10.1016\/j.bone.2025.117684","journal-title":"Bone"},{"issue":"2","key":"10431_CR20","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s00277-017-3184-6","volume":"97","author":"F Schyrr","year":"2018","unstructured":"Schyrr F et al (2018) Correlation study between osteoporosis and hematopoiesis in the context of adjuvant chemotherapy for breast cancer. Ann Hematol 97(2):309\u2013317. https:\/\/doi.org\/10.1007\/s00277-017-3184-6","journal-title":"Ann Hematol"},{"issue":"6","key":"10431_CR21","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.tem.2022.03.003","volume":"33","author":"G Pach\u00f3n-Pe\u00f1a","year":"2022","unstructured":"Pach\u00f3n-Pe\u00f1a G, Bredella MA (2022) Bone marrow adipose tissue in metabolic health. Trends Endocrinol Metab 33(6):401\u2013408. https:\/\/doi.org\/10.1016\/j.tem.2022.03.003","journal-title":"Trends Endocrinol Metab"},{"key":"10431_CR22","doi-asserted-by":"publisher","unstructured":"MarinelliBusilacchi E, Morsia E, Poloni A (2024) Bone marrow adipose tissue. Cells 13(9):724 https:\/\/doi.org\/10.3390\/cells13090724","DOI":"10.3390\/cells13090724"},{"issue":"4","key":"10431_CR23","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s11914-018-0453-9","volume":"16","author":"JD Diedrich","year":"2018","unstructured":"Diedrich JD et al (2018) The lipid side of bone marrow adipocytes: how tumor cells adapt and survive in bone. Curr Osteoporos Rep 16(4):443\u2013457. https:\/\/doi.org\/10.1007\/s11914-018-0453-9","journal-title":"Curr Osteoporos Rep"},{"issue":"6","key":"10431_CR24","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1080\/14737140.2025.2492784","volume":"25","author":"J Poswal","year":"2025","unstructured":"Poswal J, Mandal CC (2025) Lipid metabolism dysregulation for bone metastasis and its prevention. Expert Rev Anticancer Ther 25(6):657\u2013673. https:\/\/doi.org\/10.1080\/14737140.2025.2492784","journal-title":"Expert Rev Anticancer Ther"},{"key":"10431_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/cancers18060966","author":"MM Pasca Fenesan","year":"2026","unstructured":"Pasca Fenesan MM et al (2026) Breast cancer-associated adipose tissue histologic subtypes: microscopic characterization and their impact on prognosis and survival, depending on age. Cancers (Basel) 18(6):966. https:\/\/doi.org\/10.3390\/cancers18060966","journal-title":"Cancers (Basel)"},{"issue":"14","key":"10431_CR26","doi-asserted-by":"publisher","first-page":"6950","DOI":"10.18632\/aging.204885","volume":"15","author":"M Zhang","year":"2023","unstructured":"Zhang M et al (2023) Single-cell sequencing analysis reveals the relationship between tumor microenvironment cells and oxidative stress in breast cancer bone metastases. Aging 15(14):6950\u20136968. https:\/\/doi.org\/10.18632\/aging.204885","journal-title":"Aging"},{"issue":"6","key":"10431_CR27","doi-asserted-by":"publisher","first-page":"116225","DOI":"10.1016\/j.isci.2026.116225","volume":"29","author":"H Duan","year":"2026","unstructured":"Duan H, Qi J, Hu X (2026) The osteoporotic niche as a metabolic sanctuary for breast cancer dormancy and reactivation: a mechanistic perspective. iScience 29(6):116225. https:\/\/doi.org\/10.1016\/j.isci.2026.116225","journal-title":"iScience"},{"key":"10431_CR28","doi-asserted-by":"publisher","first-page":"100609","DOI":"10.1016\/j.jbo.2024.100609","volume":"46","author":"H Fairfield","year":"2024","unstructured":"Fairfield H et al (2024) Adipocytes and metabolism: contributions to multiple myeloma. J Bone Oncol 46:100609. https:\/\/doi.org\/10.1016\/j.jbo.2024.100609","journal-title":"J Bone Oncol"},{"issue":"4","key":"10431_CR29","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s11914-024-00879-x","volume":"22","author":"D Trivanovi\u0107","year":"2024","unstructured":"Trivanovi\u0107 D et al (2024) Molecular deconvolution of bone marrow adipose tissue interactions with malignant hematopoiesis: potential for new therapy development. Curr Osteoporos Rep 22(4):367\u2013377. https:\/\/doi.org\/10.1007\/s11914-024-00879-x","journal-title":"Curr Osteoporos Rep"},{"issue":"4","key":"10431_CR30","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.7150\/ijbs.65227","volume":"18","author":"C Zhou","year":"2022","unstructured":"Zhou C et al (2022) Cancer-associated adipocytes promote the invasion and metastasis in breast cancer through LIF\/CXCLs positive feedback loop. Int J Biol Sci 18(4):1363\u20131380. https:\/\/doi.org\/10.7150\/ijbs.65227","journal-title":"Int J Biol Sci"},{"key":"10431_CR31","doi-asserted-by":"publisher","unstructured":"Wu C et al (2023) Cancer-associated adipocytes and breast cancer: intertwining in the tumor microenvironment and challenges for cancer therapy. Cancers (Basel) 315 15(3):726. https:\/\/doi.org\/10.3390\/cancers15030726","DOI":"10.3390\/cancers15030726"},{"issue":"7","key":"10431_CR32","doi-asserted-by":"publisher","first-page":"606","DOI":"10.20892\/j.issn.2095-3941.2023.0309","volume":"21","author":"S Tan","year":"2024","unstructured":"Tan S et al (2024) ACSL3 regulates breast cancer progression via lipid metabolism reprogramming and the YES1\/YAP axis. Cancer Biol Med 21(7):606\u2013635. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2023.0309","journal-title":"Cancer Biol Med"},{"issue":"1\u20132","key":"10431_CR33","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s11010-018-3332-x","volume":"448","author":"Y Radif","year":"2018","unstructured":"Radif Y et al (2018) The endogenous subcellular localisations of the long chain fatty acid-activating enzymes ACSL3 and ACSL4 in sarcoma and breast cancer cells. Mol Cell Biochem 448(1\u20132):275\u2013286. https:\/\/doi.org\/10.1007\/s11010-018-3332-x","journal-title":"Mol Cell Biochem"},{"issue":"7","key":"10431_CR34","doi-asserted-by":"publisher","first-page":"103628","DOI":"10.1016\/j.drudis.2023.103628","volume":"28","author":"W George Warren","year":"2023","unstructured":"George Warren W et al (2023) The emerging role of fatty acid binding protein 5 (FABP5) in cancers. Drug Discov Today 28(7):103628. https:\/\/doi.org\/10.1016\/j.drudis.2023.103628","journal-title":"Drug Discov Today"},{"issue":"1","key":"10431_CR35","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s12672-025-02117-x","volume":"16","author":"X Jiang","year":"2025","unstructured":"Jiang X et al (2025) Expression profiles of FABP4 and FABP5 in breast cancer: clinical implications and perspectives. Discov Oncol 16(1):357. https:\/\/doi.org\/10.1007\/s12672-025-02117-x","journal-title":"Discov Oncol"},{"key":"10431_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13071488","author":"A Ruiz-Iglesias","year":"2021","unstructured":"Ruiz-Iglesias A, Ma\u00f1es S (2021) The importance of mitochondrial pyruvate carrier in cancer cell metabolism and tumorigenesis. Cancers (Basel) 13(7):1488. https:\/\/doi.org\/10.3390\/cancers13071488","journal-title":"Cancers (Basel)"},{"key":"10431_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26199781","author":"A Dabaliz","year":"2025","unstructured":"Dabaliz A et al (2025) Adipocyte-tumor interactions in the bone marrow niche: implications for metastasis and therapy. Int J Mol Sci 26(19):9781. https:\/\/doi.org\/10.3390\/ijms26199781","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10431_CR38","doi-asserted-by":"publisher","first-page":"e19858","DOI":"10.1002\/advs.202519858","volume":"13","author":"D Yang","year":"2026","unstructured":"Yang D, Yang J, Wang G (2026) Targeting the Hyperglycemic pre-metastatic niche to prevent breast cancer bone metastasis: mechanisms and therapeutic strategies. Adv Sci (Weinh) 13(7):e19858. https:\/\/doi.org\/10.1002\/advs.202519858","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"10431_CR39","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1186\/s12951-025-03792-2","volume":"23","author":"J Dong","year":"2025","unstructured":"Dong J et al (2025) Targeting bone marrow adipocyte-driven fatty acid metabolism to overcome drug resistance in lung cancer bone metastasis. J Nanobiotechnol 23(1):709. https:\/\/doi.org\/10.1186\/s12951-025-03792-2","journal-title":"J Nanobiotechnol"},{"issue":"16","key":"10431_CR40","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1056\/NEJMra030831","volume":"350","author":"GD Roodman","year":"2004","unstructured":"Roodman GD (2004) Mechanisms of bone metastasis. N Engl J Med 350(16):1655\u20131664. https:\/\/doi.org\/10.1056\/NEJMra030831","journal-title":"N Engl J Med"},{"issue":"6","key":"10431_CR41","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nrc3055","volume":"11","author":"KN Weilbaecher","year":"2011","unstructured":"Weilbaecher KN, Guise TA, McCauley LK (2011) Cancer to bone: a fatal attraction. Nat Rev Cancer 11(6):411\u2013425. https:\/\/doi.org\/10.1038\/nrc3055","journal-title":"Nat Rev Cancer"},{"key":"10431_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10112958","author":"R Nehme","year":"2022","unstructured":"Nehme R et al (2022) Targeting adiponectin in breast cancer. Biomedicines 10(11):2958. https:\/\/doi.org\/10.3390\/biomedicines10112958","journal-title":"Biomedicines"},{"key":"10431_CR43","doi-asserted-by":"publisher","first-page":"2946409","DOI":"10.1155\/2018\/2946409","volume":"2018","author":"FS Fan","year":"2018","unstructured":"Fan FS, Yang CF, Wang YF (2018) Diffuse bone marrow metastasis as the initial presentation of an occult breast cancer. Case Rep Oncol Med 2018:2946409. https:\/\/doi.org\/10.1155\/2018\/2946409","journal-title":"Case Rep Oncol Med"},{"key":"10431_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25137133","author":"B Dai","year":"2024","unstructured":"Dai B, Clark AM, Wells A (2024) Mesenchymal stem cell-secreted exosomes and soluble signals regulate breast cancer metastatic dormancy: current progress and future outlook. Int J Mol Sci 25(13):7133 https:\/\/doi.org\/10.3390\/ijms25137133","journal-title":"Int J Mol Sci"},{"key":"10431_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15113021","author":"R Wieder","year":"2023","unstructured":"Wieder R (2023) Awakening of dormant breast cancer cells in the bone marrow. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers15113021","journal-title":"Cancers (Basel)"},{"key":"10431_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/ijms262411893","author":"M Bakir","year":"2025","unstructured":"Bakir M et al (2025) Microenvironmental and molecular pathways driving dormancy escape in bone metastases. Int J Mol Sci 26(24):11893. https:\/\/doi.org\/10.3390\/ijms262411893","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10431_CR47","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/ncb2767","volume":"15","author":"CM Ghajar","year":"2013","unstructured":"Ghajar CM et al (2013) The perivascular niche regulates breast tumour dormancy. Nat Cell Biol 15(7):807\u2013817. https:\/\/doi.org\/10.1038\/ncb2767","journal-title":"Nat Cell Biol"},{"issue":"2","key":"10431_CR48","doi-asserted-by":"publisher","first-page":"e00485","DOI":"10.1002\/adbi.202500485","volume":"10","author":"Z Sun","year":"2026","unstructured":"Sun Z et al (2026) Dormancy and recurrence in breast cancer bone metastasis: from mechanisms to clinical translation. Adv Biol (Weinh) 10(2):e00485. https:\/\/doi.org\/10.1002\/adbi.202500485","journal-title":"Adv Biol (Weinh)"},{"issue":"6","key":"10431_CR49","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1111\/cas.15786","volume":"114","author":"S Sato","year":"2023","unstructured":"Sato S et al (2023) Bone marrow adipocytes induce cancer-associated fibroblasts and immune evasion, enhancing invasion and drug resistance. Cancer Sci 114(6):2674\u20132688. https:\/\/doi.org\/10.1111\/cas.15786","journal-title":"Cancer Sci"},{"key":"10431_CR50","doi-asserted-by":"publisher","unstructured":"Teijeiro A et al (2026) Bone marrow B cell collapse promotes bone metastasis in breast cancer. bioRxiv. https:\/\/doi.org\/10.64898\/2026.04.21.720007","DOI":"10.64898\/2026.04.21.720007"},{"key":"10431_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14204990","author":"X Jiang","year":"2022","unstructured":"Jiang X et al (2022) Recent advances in the aging microenvironment of breast cancer. Cancers (Basel) 14(20):4990. https:\/\/doi.org\/10.3390\/cancers14204990","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10431_CR52","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1186\/s12964-024-01861-x","volume":"22","author":"N Wang","year":"2024","unstructured":"Wang N et al (2024) Senescent cells promote breast cancer cells motility by secreting GM-CSF and bFGF that activate the JNK signaling pathway. Cell Commun Signal 22(1):478. https:\/\/doi.org\/10.1186\/s12964-024-01861-x","journal-title":"Cell Commun Signal"},{"issue":"3","key":"10431_CR53","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1158\/0008-5472.Can-20-1088","volume":"81","author":"H Fairfield","year":"2021","unstructured":"Fairfield H et al (2021) Myeloma-modified adipocytes exhibit metabolic dysfunction and a senescence-associated secretory phenotype. Cancer Res 81(3):634\u2013647. https:\/\/doi.org\/10.1158\/0008-5472.Can-20-1088","journal-title":"Cancer Res"},{"issue":"11","key":"10431_CR54","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/s42255-020-00298-z","volume":"2","author":"CCS Chini","year":"2020","unstructured":"Chini CCS et al (2020) CD38 ecto-enzyme in immune cells is induced during aging and regulates NAD(+) and NMN levels. Nat Metab 2(11):1284\u20131304. https:\/\/doi.org\/10.1038\/s42255-020-00298-z","journal-title":"Nat Metab"},{"issue":"1","key":"10431_CR55","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s10549-017-4308-3","volume":"165","author":"C Fan","year":"2017","unstructured":"Fan C et al (2017) Combination breast cancer chemotherapy with doxorubicin and cyclophosphamide damages bone and bone marrow in a female rat model. Breast Cancer Res Treat 165(1):41\u201351. https:\/\/doi.org\/10.1007\/s10549-017-4308-3","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"10431_CR56","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00774-015-0679-x","volume":"34","author":"C Fan","year":"2016","unstructured":"Fan C et al (2016) Combination chemotherapy with cyclophosphamide, epirubicin and 5-fluorouracil causes trabecular bone loss, bone marrow cell depletion and marrow adiposity in female rats. J Bone Min Metab 34(3):277\u2013290. https:\/\/doi.org\/10.1007\/s00774-015-0679-x","journal-title":"J Bone Min Metab"},{"issue":"3","key":"10431_CR57","doi-asserted-by":"publisher","first-page":"4180","DOI":"10.1002\/jcb.27705","volume":"120","author":"AMC Lee","year":"2019","unstructured":"Lee AMC et al (2019) Individual or combination treatments with lapatinib and paclitaxel cause potential bone loss and bone marrow adiposity in rats. J Cell Biochem 120(3):4180\u20134191. https:\/\/doi.org\/10.1002\/jcb.27705","journal-title":"J Cell Biochem"},{"issue":"1","key":"10431_CR58","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1038\/s41467-025-67793-3","volume":"17","author":"GK Raut","year":"2025","unstructured":"Raut GK et al (2025) Chemotherapy-induced adipo-lineage cell senescence drives bone loss. Nat Commun 17(1):1042. https:\/\/doi.org\/10.1038\/s41467-025-67793-3","journal-title":"Nat Commun"},{"issue":"1","key":"10431_CR59","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1186\/s12891-019-2916-2","volume":"20","author":"M Dieckmeyer","year":"2019","unstructured":"Dieckmeyer M et al (2019) Vertebral bone marrow fat fraction changes in postmenopausal women with breast cancer receiving combined aromatase inhibitor and bisphosphonate therapy. BMC Musculoskelet Disord 20(1):515. https:\/\/doi.org\/10.1186\/s12891-019-2916-2","journal-title":"BMC Musculoskelet Disord"},{"issue":"4","key":"10431_CR60","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1007\/s00330-023-10189-y","volume":"34","author":"FG Gassert","year":"2024","unstructured":"Gassert FG et al (2024) Longitudinal MR-based proton-density fat fraction (PDFF) and T2* for the assessment of associations between bone marrow changes and myelotoxic chemotherapy. Eur Radiol 34(4):2437\u20132444. https:\/\/doi.org\/10.1007\/s00330-023-10189-y","journal-title":"Eur Radiol"},{"key":"10431_CR61","doi-asserted-by":"publisher","first-page":"100355","DOI":"10.1016\/j.jbo.2021.100355","volume":"28","author":"K Waqas","year":"2021","unstructured":"Waqas K et al (2021) Updated guidance on the management of cancer treatment-induced bone loss (CTIBL) in pre- and postmenopausal women with early-stage breast cancer. J Bone Oncol 28:100355. https:\/\/doi.org\/10.1016\/j.jbo.2021.100355","journal-title":"J Bone Oncol"},{"issue":"12","key":"10431_CR62","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1002\/jbmr.4422","volume":"36","author":"A Gaculenko","year":"2021","unstructured":"Gaculenko A et al (2021) Systemic PPAR\u03b3 antagonism reduces metastatic tumor progression in adipocyte-rich bone in excess weight male rodents. J Bone Min Res 36(12):2440\u20132452. https:\/\/doi.org\/10.1002\/jbmr.4422","journal-title":"J Bone Min Res"},{"issue":"1","key":"10431_CR63","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41413-023-00273-w","volume":"11","author":"F Wei","year":"2023","unstructured":"Wei F et al (2023) A novel multifunctional radioprotective strategy using P7C3 as a countermeasure against ionizing radiation-induced bone loss. Bone Res 11(1):34. https:\/\/doi.org\/10.1038\/s41413-023-00273-w","journal-title":"Bone Res"},{"issue":"22","key":"10431_CR64","doi-asserted-by":"publisher","first-page":"e09980","DOI":"10.1002\/advs.202509980","volume":"13","author":"HL Wang","year":"2026","unstructured":"Wang HL et al (2026) The osteoblastic microenvironment determines the fate of breast cancer cells disseminated in the bone marrow. Adv Sci (Weinh) 13(22):e09980. https:\/\/doi.org\/10.1002\/advs.202509980","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"10431_CR65","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.apsb.2021.06.012","volume":"12","author":"C Liu","year":"2022","unstructured":"Liu C et al (2022) The osteogenic niche-targeted arsenic nanoparticles prevent colonization of disseminated breast tumor cells in the bone. Acta Pharm Sin B 12(1):364\u2013377. https:\/\/doi.org\/10.1016\/j.apsb.2021.06.012","journal-title":"Acta Pharm Sin B"},{"key":"10431_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17030388","author":"BG Wajda","year":"2025","unstructured":"Wajda BG et al (2025) Denosumab vs. zoledronic acid for metastatic bone disease: a comprehensive systematic review and meta-analysis of randomized controlled trials. Cancers (Basel) 17(3):388. https:\/\/doi.org\/10.3390\/cancers17030388","journal-title":"Cancers (Basel)"},{"key":"10431_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17172933","author":"M Anbalagan","year":"2025","unstructured":"Anbalagan M et al (2025) Bone targeted parathyroid hormone antagonists for prevention of breast cancer bone metastases. Cancers (Basel) 17(17):2933 https:\/\/doi.org\/10.3390\/cancers17172933","journal-title":"Cancers (Basel)"},{"key":"10431_CR68","doi-asserted-by":"publisher","DOI":"10.1530\/erc-24-0294","author":"HQ Duong","year":"2025","unstructured":"Duong HQ, Kafer G, Maugham-Macan M (2025) Bone metastasis in endocrine-related cancer: unravelling invasion and destruction. Endocr Relat Cancer 32(2):e240294. https:\/\/doi.org\/10.1530\/erc-24-0294","journal-title":"Endocr Relat Cancer"},{"key":"10431_CR69","doi-asserted-by":"publisher","first-page":"156309","DOI":"10.1016\/j.prp.2025.156309","volume":"277","author":"Y Wang","year":"2026","unstructured":"Wang Y et al (2026) Multi-dimensional targeting of the tumor microenvironment to inhibit the invasion and metastasis of breast cancer. Pathol Res Pract 277:156309. https:\/\/doi.org\/10.1016\/j.prp.2025.156309","journal-title":"Pathol Res Pract"},{"key":"10431_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11113066","author":"A Softah","year":"2023","unstructured":"Softah A et al (2023) The combination of radiation with PARP inhibition enhances senescence and sensitivity to the Senolytic, Navitoclax, in triple negative breast tumor cells. Biomedicines 11(11):3066. https:\/\/doi.org\/10.3390\/biomedicines11113066","journal-title":"Biomedicines"}],"container-title":["Clinical &amp; Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-026-10431-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10585-026-10431-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-026-10431-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T10:54:09Z","timestamp":1789642449000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10585-026-10431-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":70,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["10431"],"URL":"https:\/\/doi.org\/10.1007\/s10585-026-10431-z","relation":{},"ISSN":["1573-7276"],"issn-type":[{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]},"assertion":[{"value":"24 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"48"}}